Tuesday - April 23, 2024
Sen. Tammy Baldwin to FDA: Hold AveXis Accountable for Falsifying Data
August 09, 2019
WASHINGTON, Aug. 9 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:

* * *

- Baldwin, colleagues slam pharmaceutical company for falsifying data on gene therapy that carries a record $2.1 million price tag

* * *

Today, U.S. Senator Tammy Baldwin, along with her colleagues Senators Dick Durbin (D-IL), Bernie Sanders (I-VT), Elizabeth Warren (D-MA) and Richard Blumenthal (D-CT) blasted AveXis, a subdivision of pharmaceutical . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products